As a loss of TP53 function via nonsense or missense mutation is known to be transforming, cancer initiation may occur when BRM polymorphisms drive BRM silencing, which in turn fosters transformation by thwarting or impairing TP53 function. The gene discussed is TP53; the disease is cancer.